{
    "clinical_study": {
        "@rank": "117674", 
        "acronym": "ANOPEC2", 
        "arm_group": {
            "arm_group_label": "Blood donors", 
            "description": "Blood donors with no exclusion criteria i.e with a very low probability to have an aortic aneurysm"
        }, 
        "biospec_descr": {
            "textblock": "Blood"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "Circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- have been\n      shown to be inversely correlated to aortic aneurysm size. However reference values have not\n      yet been determined. This study is aimed to determine reference values of CD34+144+CD14- et\n      CD34+VEGF-R2+CD14-  in healthy men and women blood donors."
        }, 
        "brief_title": "Reference Values of Circulating Endothelial Progenitor Cells", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Aneurysm", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm"
            ]
        }, 
        "detailed_description": {
            "textblock": "At the time of blood donation, 10mL of blood will be used to calculate the concentration of\n      circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- , and the\n      ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all\n      circulating endothelial progenitor cells in order to determine reference values."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Blood donors\n\n        Exclusion Criteria:\n\n          -  age over 65\n\n          -  Arterial hypertension (treated or not)\n\n          -  Vascular disease\n\n          -  smoker or former smoker who stopped smoking for less than a year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy blood donors"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01918969", 
            "org_study_id": "13/408"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Endothelial progenitor cells", 
            "Healthy blood donors"
        ], 
        "lastchanged_date": "August 7, 2013", 
        "location": {
            "contact": {
                "email": "sidney.chocron@univ-fcomte.fr", 
                "last_name": "Sidney Chocron, MD, PhD", 
                "phone": "+33381533121"
            }, 
            "facility": {
                "address": {
                    "city": "Besan\u00e7on", 
                    "country": "France", 
                    "zip": "25030"
                }, 
                "name": "CHU Besan\u00e7on"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Determination of Reference Values of Circulating Endothelial Progenitor Cells CD34+144+CD14- and CD34+VEGF-R2+CD14- in a Blood Donnor Population", 
        "overall_contact": {
            "email": "sidney.chocron@univ-fcomte.fr", 
            "last_name": "Sidney Chocron, MD, PhD", 
            "phone": "+33381533121"
        }, 
        "overall_contact_backup": {
            "email": "sidney.chocron@univ-fcomte.fr", 
            "last_name": "Sidney Chocron, MD,PhD", 
            "phone": "+33381533121"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Franche-Comte; France", 
                "last_name": "Andrea Perrotti, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Etablissement Fran\u00e7ais du Sang", 
                "last_name": "Pascal Morel, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Franche-Comte. france", 
                "last_name": "Siamak Davani, MD, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Health agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Concentration of circulating endothelial progenitor cells CD34+144+CD14- and CD34+VEGF-R2+CD14-", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "reference": {
            "PMID": "21481600", 
            "citation": "Parietti E, Pallandre JR, Deschaseaux F, Aup\u00e8cle B, Durst C, Kantelip JP, Chocron S, Davani S. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1\u03b1 are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg. 2011 Jul;40(1):e6-12. doi: 10.1016/j.ejcts.2011.02.065. Epub 2011 Apr 9."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01918969"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hopital Jean Minjoz", 
            "investigator_full_name": "Prof. Sidney Chocron", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Ratio of circulating endothelial progenitor cells CD34+144+CD14- et CD34+VEGF-R2+CD14- / all circulating endothelial progenitor cells", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Hopital Jean Minjoz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Jean Minjoz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}